Modelling time–kill studies to discern the pharmacodynamics of meropenem
Open Access
- 1 May 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 55 (5) , 699-706
- https://doi.org/10.1093/jac/dki086
Abstract
Objectives: Time–kill studies are commonly used in investigations of new antimicrobial agents. However, they typically provide descriptive information on pharmacodynamics. We developed a mathematical model to capture the relationship between microbial burden and antimicrobial agent concentrations. Methods: Time–kill studies were performed with 108 cfu/mL of Pseudomonas aeruginosa at baseline. Meropenem at 0, 0.25, 1, 4, 16 and 64 × MIC was used (MIC = 1 mg/L). Serial samples were obtained to quantify bacterial burden over 24 h. The data were analysed by a population analysis using the non-parametric adaptive grid program. The rate of change of bacteria over time was expressed as the difference between linear bacterial growth rate and sigmoidal kill rate. Regrowth was attributed to adaptation, which was explicitly modelled as increase in C50k (concentration to achieve 50% maximal kill rate), using a saturable function of selective pressure (both meropenem concentration and time). Results: The best-fit model consisted of eight parameters and the fit to the data was satisfactory. The r2 of maximum a-posteriori probability Bayesian predictions based on the mean parameter estimates was 0.984. Maximal killing rate at baseline was found to be 4.7 h−1; C90k was achieved with meropenem at 5.0 mg/L. The model was validated by time–kill studies using 2× and 32× MIC of meropenem. Conclusions: Our model reasonably described and predicted the time course of P. aeruginosa in time–kill studies, and provided quantitative information on the pharmacodynamics of meropenem. The structural model appeared robust and could be used to provide a realistic expectation of the killing performance of antimicrobial agents.Keywords
This publication has 24 references indexed in Scilit:
- Pharmacodynamic Functions: a Multiparameter Approach to the Design of Antibiotic Treatment RegimensAntimicrobial Agents and Chemotherapy, 2004
- Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'Nature Reviews Microbiology, 2004
- Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Kill Curves versus MICAntimicrobial Agents and Chemotherapy, 2004
- Pharmacodynamics of a New Triazole, Posaconazole, in a Murine Model of Disseminated CandidiasisAntimicrobial Agents and Chemotherapy, 2004
- Structured Treatment Interruption in Patients with Multidrug-Resistant Human Immunodeficiency VirusNew England Journal of Medicine, 2003
- Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection modelJournal of Antimicrobial Chemotherapy, 2003
- Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000)Diagnostic Microbiology and Infectious Disease, 2002
- Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due toPseudomonas aeruginosaJournal of Pharmacokinetics and Biopharmaceutics, 1988
- A Pharmacodynamic Model for the Activity of Antibiotics Against Microorganisms under Nonsaturable ConditionsJournal of Pharmaceutical Sciences, 1986
- BEHAVIOR OF MIXED CULTURES OF MICROORGANISMSAnnual Review of Microbiology, 1977